REG - Genus - Total Voting Rights

GenusAnnouncement

01/05/2018 16:40

2018-05-01T15:39:07.009Zreuters.comtag:reuters.com,2018-05-01:newsml_RSA7998Ma:13TXT
This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-05-01T15:39:07.009Z2018-05-01T15:39:07.009Z_UCDP:parsn_lse_10.54.132.131_1.2.37102:2019-06-01T15:39:07.009Z3RSA7998MaREG - Genus  - Total Voting RightsHealthcare (TRBC level 1)Pharmaceuticals & Medical Research (TRBC level 2)Biotechnology & Medical Research (TRBC level 4)Biotechnology & Medical Research (NEC) (TRBC level 5)Western EuropeUnited KingdomEuropeSuggested SourcesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsEurope daily earnings hits & missesGenus PLC








RNS Number : 7998M
Genus PLC
01 May 2018
 

1 May 2018
Genus plc
Total Voting Rights
Genus plc (LSE: GNS) announces that, as at 30 April 2018, its issued share capital consists of 61,542,467 ordinary shares of 10p each with voting rights ('Ordinary Shares'). No Ordinary Shares are currently held in treasury and the voting rights of all the Ordinary Shares are identical.
The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Genus under the FCA's Disclosure and Transparency Rules.
 
For further information please contact:
 
Genus:
Cara Crichton, Deputy Company Secretary                                           Tel: +44 (0)1256 347100
 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRLLFVEETILIIT